Summary of data publicly reported by the Centers for Disease Control and Prevention
Date: 9/21/22

The American Academy of Pediatrics recommends COVID-19 vaccination for all children and adolescents 6 months of age and older who do not have contraindications using a vaccine authorized for use for their age. See AAP policy.

In this report, drawing on data posted by the Centers for Disease Control and Prevention (CDC) as of 9.21.22, the AAP reports progress in vaccinating US children, including the 50 States and District of Columbia.

The report covers the vaccine data available for children 6 months-4 years, and the longer-term data for children 5-11 years and for children 12-17 years of age.

In this week’s report we include an addition, comparing the trends in the receipt of vaccines following the first 14 weeks of vaccine authorization, by the 3 child age groups.

See link below to download the full AAP report. Note: Individual state web sites may have additional or more recent information.

Children Ages 6 Months-4 Years:

As of September 21, 2022, the CDC recorded:

1.4 million US children ages 6 months-4 years have received at least one dose of COVID-19 vaccine

  • Representing 8% of 6 months-4 year-olds
  • This past week about 51,000 received their first vaccine dose.

About 15.6 million children 6 months-4 year-olds had yet to receive their first COVID-19 vaccine dose.

Child vaccination rates vary widely across states, ranging from 2% to 32% receiving their first dose.

Children Ages 5-11 Years:

10.7 million US children ages 5-11 have received at least one dose of COVID-19 vaccine

  • Representing 38% of 5-11 year-olds

8.8 million US children ages 5-11 completed the 2-dose vaccination series

  • Representing 31% of 5-11 year-olds

About 17.9 million children 5-11 had yet to receive their first COVID-19 vaccine dose. This past week about 28,000 received their first vaccine dose.

Child vaccination rates vary widely across states, ranging from 17% to 72% receiving their first dose.

Children Ages 12-17 Years:

17.6 million US children and adolescents ages 12- 17 have received at least one dose of COVID-19 vaccine

  • Representing 67% of 12-17 year-olds

15.0 million of US children and adolescents ages 12- 17 completed the 2-dose vaccination series

  • Representing 57% of 12-17 year-olds

About 8.6 million children 12-17 had yet to receive their first COVID-19 vaccine dose. This past week about 18,000 received their first vaccine dose.

Child vaccination rates vary widely across states, ranging from 39% to 100% receiving their first dose.

ages 5-11 initial covid vaccine 9.21.22.png

Trends Across the 3 Child Age Groups:

The receipt of at least one dose of the COVID-19 vaccine has varied across the 3 child age groups at comparable stages following the authorization of the vaccine

At 14 weeks following vaccine authorization:

  • Children Ages 5 Months-4 Years: 8% had received at least one dose of COVID-19 vaccine
  • Children Ages 5-11 Years: 30% had received at least one dose of COVID-19 vaccine
  • Children Ages 12-17 Years: 37% had received at least one dose of COVID-19 vaccine

Portion of US Children who have received vaccination:

Across the total of US children 6 mos to 17 years, approximately 59% have not received a first dose of the COVID-19 vaccine

Source: AAP analysis of data series titled “COVID -19 Vaccinations in the United States, Jurisdiction” as of September 21, 2022. Data cover the 50 States and District of Columbia.

There are 73.6 M children under age 18 in the US, 22% of the population (Census 2021).

The Pfizer-BioNTech COVID-19 vaccine was approved by the CDC in persons aged > 16 years on December 12, 2020, following an EUA from the FDA on December 11th. On May 12, 2021, CDC approved the use of the Pfizer-BioNTech COVID-19 vaccine in persons aged 12-15 years, following the vaccine’s EUA granted by the FDA on May 10th. The FDA issued an EUA for the Pfizer vaccine for kids aged 5 to 11 on 10.29.2021, followed by CDC recommendation on 11.2.2021.

The FDA authorized the use of Moderna and Pfizer-BioNTech COVID-19 vaccines for children 6 months-4 years on 6.15.2022, followed by CDC recommendation on 6.18.2022.

Download the Full Report 9/21/2022

Download the Full Report 9/14/2022

Download the Full Report 9/7/2022

Last Updated

09/21/2022

Source

American Academy of Pediatrics